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Abstract
Background: Hospital strains of Enterococcus faecium could be characterized and typed by various molecular
methods (MLST, AFLP, MLVA) and allocated to a distinct clonal complex known as MLST CC17. However, these
techniques are laborious, time-consuming and cost-intensive. Our aim was to identify hospital E. faecium strains
and differentiate them from colonizing and animal variants by a simple, inexpensive and reliable PCR-based
screening assay. We describe here performance and predictive value of a single PCR detecting the insertion
element, IS16, to identify hospital E. faecium isolates within a collection of 260 strains of hospital, animal and
human commensal origins.
Methods: Specific primers were selected amplifying a 547-bp fragment of IS16. Presence of IS16 was determined
by PCR screenings among the 260 E. faecium isolates. Distribution of IS16 was compared with a prevalence of
commonly used markers for hospital strains, esp and hylEfm. All isolates were typed by MLST and partly by PFGE.
Location of IS16 was analysed by Southern hybridization of plasmid and chromosomal DNA.
Results: IS16 was exclusively distributed only among 155 invasive strains belonging to the clonal complex of
hospital-associated strains (“CC17”; 28 MLST types) and various vancomycin resistance genotypes (vanA/B/negative).
The five invasive IS16-negative strains did not belong to the clonal complex of hospital-associated strains (CC17).
IS16 was absent in all but three isolates from 100 livestock, food-associated and human commensal strains (“non-
CC17”; 64 MLST types). The three IS16-positive human commensal isolates revealed MLST types belonging to the
clonal complex of hospital-associated strains (CC17). The values predicting a hospital-associated strain (“CC17”)
deduced from presence and absence of IS16 was 100% and thus superior to screening for the presence of esp
(66%) and/or hylEfm (46%). Southern hybridizations revealed chromosomal as well as plasmid localization of IS16.
Conclusions: This simple screening assay for insertion element IS16 is capable of differentiating hospital-associated
from human commensal, livestock- and food-associated E. faecium strains and thus allows predicting the epidemic
strengths or supposed pathogenic potential of a given E. faecium isolate identified within the nosocomial setting.
Background
Vancomycin- and multi-resistant Enterococcus strains,
especially strains of E. faecium, raise major concerns in
intensive care medicine due to limited treatment options
[1]. E. faecium is ecologically widely distributed and
expected to play a central role as a reservoir and “turn-
table” for antibiotic resistance determinants in the bac-
terial world, and especially among Gram-positive
bacteria [2]. A number of molecular typing and charac-
terization techniques such as AFLP, MLVA and MLST
and comparative genomic hybridizations allowed differ-
entiating strains of E. faecium and allocating them into
various clonal complexes as based on core as well as
accessory genome content [3,4]. Isolates belonging to
hospital-associated clonal types (for instance, MLST
C C 1 7 )c o u l db ei d e n t i f i e da n das u p p o s e de n h a n c e d
spreading potential among the nosocomial setting for
isolates of this specific subgroup is predictable [4].
Reports from recent years described increasing annual
rates of E. faecium bacteraemia in European countries
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was due to increasing numbers of hospital-associated
clonal types of E. faecium (MLST CC17) whereas num-
bers of other clonal types remained constant over time
again emphasizing the aforementioned increased poten-
tial for nosocomial spread [5]. The molecular techniques
to identify hospital-associated E. faecium strains are
laborious, time-consuming and cost-intensive and are
thus not applicable for routine diagnostics. Results of
recent bacterial, epidemiological, microarray-based and
genomic studies suggest that a number of markers are
enriched among hospital strains of E. faecium including
collagen adhesion factors acm and scm [7,8], other
matrix-binding proteins and pili [9,10], a supposed hya-
luronidase, hylEfm [11,12], biofilm-associated markers
including the enterococcal surface protein gene, esp
[13,14], and various genomic islands encoding proteins
of unknown functions [15,16]. Having acquired a num-
ber of these aforementioned determinants, these strains
may have an increased pathogenic potential [4,10,17].
However, distribution of these markers among hospital
strains is not exclusive and thus the predictive value is
limited in terms of specificity and sensitivity. Certain
markers possess pseudogenes and partly deleted variants
complicating establishing a simple PCR based screening
test [8,17]. Acquired ampicillin resistance appeared as a
phenotypic trait of hospital strains, at least in Europe;
however, this feature is also prevalent among non-hospi-
tal strains in some parts of the world, such as Asia and
North America [18-20]. Microarray based genomic com-
parisons revealed a specific mobile element, insertion
element IS16, exclusively prevalent among hospital
E. faecium strains from an international collection of
isolates [3]. In the present study, we established a PCR-
based IS16 screening test and evaluated its robustness,
sensitivity, specificity and predictive value for 260 pre-
characterized isolates of E. faecium from different
human and animal sources. IS16 was localized in a sub-
set of E. faecium isolates (n = 45) representing 29
MLST types by Southern hybridization. Available E. fae-
cium genome data were examined for the presence of
IS16 homologous sequences and a genetic association of
IS16 with genomic markers is discussed.
Methods
Strain collection
Our laboratory serves as a Focal Laboratory for Entero-
cocci in Germany. In general, enterococcal isolates sent
to us are pre-selected for being vancomycin- and multi-
resistant or with the suspicion of clonal spread (local,
regional, and country-wide outbreak analysis). Our col-
lection of E. faecium test strains included 160 invasive
isolates (blood cultures) from 60 different German diag-
nostic or hospital laboratories isolated between 1995
and 2007. Blood culture strains were pre-selected by
geography and hospital origin, year of isolation, and dif-
ferent van genotypes (van-/A/B). The blood culture iso-
lates were compared against 68 human commensal
(outpatient) isolates from four different prevalence stu-
dies performed in different parts of Germany (1996,
1997, 1999, 2003) [24,25] and 32 isolates from animal
(chicken, pigs) and meat samples (broiler, pork) (1994,
1995, 1999) [21-23]. In all cases duplicate isolates were
excluded based on clinical/epidemiological data
(same patient/hospital or animal sample/flock) and of
molecular typing results (for instance, based on SmaI-
macrorestriction using PFGE for human commensal iso-
lates [24,25]; unpublished results). Antibiotic susceptibil-
ities were determined by microbouillon dilution in MH
bouillon. Ampicillin resistance is defined by an MIC of
>8 mg/L and vancomycin resistance by >4 mg/L (http://
www.eucast.org). Summarized data are presented in
Table 1 and detailed information is given in Additional
files 1, 2, 3. Ethical approval was not needed for this
study; all strains were pre-selected and were received
anonymously from German microbiological or hospital
laboratories.
DNA isolation
Genomic DNA was prepared using a DNA extraction kit
( D N e a s yT i s s u eK i t ;Q i a g e n ,Hilden, Germany) accord-
ing to the manufacturer’s instructions. An initial cell
wall lysis step was added dissolving the cell pellet in
TES buffer [10 mM Tris, 0.5 mM ethylene diamine
tetra-acetic acid (EDTA), 10% sucrose (pH 8.0)] plus
10 mg/mL lysozyme (Roche Applied Science, Man-
nheim, Germany) followed by incubation at 37°C for 30
min. Plasmid DNA was isolated using a common phe-
nol/chloroform-based alkaline lysis strategy [26].
PCR
PCR was performed with illustra™ PuRe Taq Ready-To-
Go™ PCR Beads (GE Healthcare, Freiburg, Germany)
according to the manufacturer’s instructions. Approxi-
mately 0.5 μL of isolated genomic DNA (ca. 10 ng) and
primers (200 nM each) were added. Amplification of
fragments representing the esp, hylEfm and vanA/B
genes was performed in a multiplex PCR as described
elsewhere [27]. The following strains and plasmids were
used as positive control samples: plasmid pRUM (IS16),
plasmid pLG1 (hylEfm); plasmid pIP816 (vanA;
E. faecium BM4147), E. faecium U0317 (esp), and E. fae-
calis V583 (vanB). E. faecalis OG1RF served as a nega-
tive control sample for all PCR assays. PCR primers and
conditions for screening IS16 elements were as follows:
IS16-F: 5’-CATGTTCCACGAACCAGAG and IS16-R:
5’-TCAAAAAGTGGGCTTGGC, annealing temperature
was 53°C, the predicted size of the product was 547 bp
Werner et al. BMC Infectious Diseases 2011, 11:80
http://www.biomedcentral.com/1471-2334/11/80
Page 2 of 8(reference E. faecium plasmid pRUM; GenBank acc. no.
AF507977). Primers were established using software
Acelrys DS Gene 1.5.
PFGE typing
Genomic DNA for PFGE analysis was isolated and trea-
ted as described recently [27]. The agarose gel concen-
tration was 1%, the CHEF-DR III apparatus (Bio-Rad
Laboratories, Hercules, CA, USA) was used for PFGE.
The ramped pulsed times were as follows: 1 - 11 sec for
15 h and 11 - 30 sec for 14 h at 14°C. SmaI-digested
Staphylococcus aureus NCTC 8325 was used as a mole-
cular mass standard on all PFGE gels. Chromosomal
DNA of E. faecium strains was digested with I-Ceu-I for
16 h at 37°C. Plasmids were linearized by S1 nuclease
(TaKaRa, Germany) treatment for 15 min (37°C) and
subsequent resolution of the linearized plasmid DNA in
PFGE. The ramped pulsed times for I-Ceu-I gels were
5 - 30 sec for 22 h and for S1 PFGE 5 - 35 sec for 22 h
at 14°C [28].
Southern hybridizations
Southern hybridization experiments were done as
described elsewhere using a PCR-generated digoxigenin-
labelled IS16 probe (DIG High Prime; Roche Applied
Science, D), hybridization chemicals and equipment
from commercial kits and according to recommenda-
tions of the manufacturer (Roche, Germany). Immuno-
logical detection was done as recommended using a
chemiluminescent probe (CDP-Star™,R o c h e ,D )a n d
several readouts were taken at 10, 30, 60 and 120 min
in a chemi-imager from Bio-Rad (Chemidoc XRS, Bio-
Rad Labs., Hercules, US).
MLST and DNA sequencing
PCRs amplifying the seven loci used for MLST were
done according to the reference (http://efaecium.mlst.
net/). Sequencing reactions were performed according
to the manufacturer’s recommendations for cycle
sequencing of PCR products (Applied Biosystems,
Germany). Sequence files were read, evaluated, aligned
and compared to the reference set of alleles using
sequencing software Lasergene 8.0 from DNA-STAR
( S e q M a n8 . 0 ;E d i t S e q8 . 0 ) ,T r a c e E d i t P r ov .1 . 1 . 1f r o m
Ridom (http://www.ridom.de), and via the official MLST
webpage (http://efaecium.mlst.net/). Phylogenetic trees
were generated using software programmes eBURST
[29] for the set of determined MLST types and global
optimised eBURST [30] for the entire set of all available
524 MLST types (http://efaecium.mlst.net/).
Statistics
Statistical analyses were performed with software pack-
age EpiCompare 1.0 (Ridom).
Results
Identification of IS16 primer sequences
Based on available sequences (pRUM [31] or composite
(vanB) transposons [32]) we established PCR primers
for an IS16-specific internal fragment (547 bp). Specifi-
city and sensitivity was evaluated against available bac-
terial databases (BlastN,G e n B a n k ) .T h eP C Rw a s
established using DNA from reference samples known
to be positive for IS16 (plasmid pRUM) and from nega-
tive control samples known to lack IS16 (E. faecalis
OG1RF). PCR results were as expected and amplified
products from reference samples were sequenced for
confirming specificity of the amplified PCR product (not
shown).
Screening for markers in the two sets of strains
G e n o m i cD N Aw a ss c r e e n e db yP C Ru s i n gt h ee s t a b -
lished PCR primers for IS16, esp and hylEfm.I S 16 was
highly prevalent among invasive E. faecium (n = 155/
160; Table 1) and mainly absent (n = 3/100) from
human commensal or animal and meat sources.
Table 1 Prevalence of epidemic markers among E. faecium isolates from different origins (see also Figure 1 and
Additional Files 1, 2, 3)
Origin No. of
isolates
No. of MLST
types
AmpR PCR IS16
+
PCR esp
+
PCR hylEfm
+
PCR vanA+/B
+
Blood cultures 160 32 98.1%
(n = 157)
96.9%
(n = 155)
63.8%
(n = 102)
45.6%
(n = 73)
58.1%
(n = 93)
Hosp.-associated E. faecium (CC17)
1
155 28 100%
(n = 156)
100%
(n = 156)
65.8%
(n = 102)
46.5%
(n = 72)
58.7%
(n = 91)
Human commensal 68 46 2.9%
(n = 2)
4.4%
(n = 3)
2
0% 0% 14.7%
(n = 10)
Animal commensal and meat sources 32 22 6.2%
(n = 2)
0% 0% 0% 40.6%
(n = 13)
BC MLST CC17 (second line) shown in italics (n = 155) is a subgroup of all blood culture E. faecium isolates presented in the first line representing all isolates
allocated to the clonal complex of hospital-aascoiated strains (CC17).
AmpR, ampicillin resistance;
1 including two isolates of ST65 representing a singleton but known to be found only among clinical strains;
2 all three belonged to
the clonal complex of hospital-associated strain types (MLST CC17; 2x ST18, 1x ST413; see also Additional file 4).
Werner et al. BMC Infectious Diseases 2011, 11:80
http://www.biomedcentral.com/1471-2334/11/80
Page 3 of 8The three IS16-positive commensal isolates were from
humans. Other markers supposedly enriched among
clinical or hospital-associated E. faecium isolates were
also assessed: the esp gene was prevalent among 64% of
all blood culture isolates and 46% of all invasive isolates
were hylEfm-positive (Table 1). None of the 100 non-
clinical strains possessed esp or hylEfm. Ampicillin resis-
tance was prevalent among almost all clinical strains
(98%). Two human commensal and two animal isolates
were also ampicillin-resistant.
MLST typing
All 260 E. faecium isolates were MLST typed. Discrimi-
natory power among clinical isolates (n = 160 isolates;
32 MLST types DI = 0.889 95% CI [0.864 - 0.913]) was
much less than among human and animal commensal
isolates (n = 100 isolates, 64 MLST types; DI = 0.988;
95% CI [0.983 - 0.994]). This suggests that prevalent
hospital-associated clonal types differ less than their
colonizing counterparts in animals and humans. In fact,
126 of the 160 invasive E. faecium isolates belonged to
only eight MLST types known to represent major
hospital-associated clonal types (ST16, ST17, ST18,
ST78, ST117, ST192, ST202, ST203) whereas the other
24 MLST types occurred only occasionally. Based on
their MLST types and subsequent eBURST and goe-
BURST analyses, isolates could be sorted into different
clonal complexes which were in agreement with their
corresponding ecological background (compare also to
[4]). Figure 1 shows eBURST trees generated with all
MLST types determined in this study. A phylogenetic
tree of all currently detached MLST types (n = 524;
21.04.2010; http://efaecium.mlst.net/) using goeBURST
is shown as Additional File 4. Based on these two calcu-
lations, almost all (n = 155/160) invasive isolates
belonged to the clonal complex of hospital-associated
strains (CC17 + ST65 [singleton]). The five IS16-nega-
tive clinical isolates represent colonizing strain types not
associated with clonal types of hospital strains ("non-
CC17"; ST9 [n = 2], ST104; ST271; ST374). The major-
ity of commensal isolates represented many individual
MLST types but belonging to the major clonal com-
plexes of animal and human colonizing strain types
Figure 1 eBURST cluster of MLST types generated from this set of 260 clinical, commensal and livestock-associated E. faecium strains.
(The newly identified MLST types are not presented as well as the following MLST types which appear as singletons in this set: ST39, ST74, ST94,
ST289, ST345, ST503, ST413; ST512; compare also to Additional file 4). The origin of the isolates is given in colour codes. ST19 appears here as a
singleton but belongs to CC17 when resolved among the entire set of MLST types (Additioinal file 4).
Werner et al. BMC Infectious Diseases 2011, 11:80
http://www.biomedcentral.com/1471-2334/11/80
Page 4 of 8(CC5, CC22/36, CC1). The three IS16-positive commen-
sal E. faecium isolates revealed MLST types (ST18,
ST413) belonging to the clonal complex of hospital-
associated strains (CC17).
Southern hybridizations of IS16 probes
The localization of IS16 among 45 representative
E. faecium isolates from various origins and altogether
29 different MLST types was investigated. I-Ceu-I
digested chromosomal DNA resolved in PFGE and plas-
mid DNA analysed inS1 PFGE and common agarose
gels were transferred onto nylon membranes and hybri-
dized against a labelled IS16 probe. Results are shown in
Table 2. If available, several representatives of identical
MLST types differing in their van gene content were
considered for analysis (see for instance ST17 vanA/B/-
negative isolates). In general, the IS16 probe hybridized
to (up to three) chromosomal bands suggesting several
copies of the same element present in the genome
(a single hybridizing chromosomal band could still result
from several IS16 copies on it). Four isolates (ST17,
S T 8 1 ,S T 2 0 2 ,S T 2 7 5 )s h o w e dI S 16 only hybridizing to
plasmid bands. Twenty-two strains (n = 22/45) revealed
a signal for both chromosomal as well as plasmid bands.
Hybridization patterns were independent of the van
gene content (Table 2).
Screening E. faecium genomes for IS16
Several E. faecium genomes are available as genomic
fragments for preliminary analysis (collection I: seven E.
faecium genomes; [33]; collection II: eleven E. faecium
isolates from the Human Microbiome Project; (http://
nihroadmap.nih.gov/hmp/; http://www.ncbi.nlm.nih.
gov//genomes/geblast.cgi?gi=6511#SearchSet). A BLAST
search for IS16-related sequences in both E. faecium
collections revealed several hits. However, as far as
some detailed information was available, the neighbour-
ing DNA fragments all showed different genetic links.
IS16 was prevalent among four out of seven genomes in
collection I [33]. IS16 was linked to (a) several putative
fragments of a conjugative transposon (strain E1162,
ST17), (b) ORF involved in sugar metabolism (strain
E1636; ST106), (c) a genomic fragment containing other
transposases of the IS256 family (strain U0317, ST78)
and (d) the supposed pathogenicity island containing
the esp gene (strain E1679, ST104). None of the other
two strains also containing the esp PAI possessed IS16
within its structure. In the deposited genomic fragments
from the Human Microbiome Project, IS16 was infre-
quently identified, for instance, in E. faecium 1,230,933
linked to a metal-dependent hydrolase or in E. faecium
TC6 linked to an extracellular solute-binding protein,
family 1. In E. faecium DO a 5’ link to a C4-dicarboxy-
late anaerobic carrier gene and a 3’ link to a
Table 2 Localization of IS16 to I-Ceu-I digested
chromosomal DNA resolved in PFGE and plasmid DNA as
based on Southern hybridizations
Strain
no.
Origin MLST
type
van
genotype
I-CeuI
PFGE
Plasmid
UW 6714 BC 202 -- * +
UW 1245 BC 202 vanA -+
UW 6293 BC 202 vanB -* -
#
UW 6295 BC 202 vanB -* -
#
UW 4962 BC 203 vanA +-
#
UW 6989 BC 203 -+ -
#
UW 6502 BC 208 vanB ++
UW 5918 BC 252 vanA ++
UW 4675 BC 252 vanB +-
UW 6617 BC 275 vanA -+
UW 4960 BC 279 vanB +-
UW 6033 BC 282 vanA ++
UW 4512 BC 294 -+ +
UW 6297 BC 306 -+ +
UW 6935 BC 371 -+ +
UW 3142 BC 375 vanA ++
UW 5275 BC 376 vanB ++
UW 6983 BC 377 -+ +
UW 6112 BC 378 -+ +
UW 4208 BC New -+ +
UW 6642 BC New vanA ++
AK-EM 40 HC 18 -+ +
AK-EM 53 HC 413 -+ +
K226.7 HC 18 -+ -
UW 2055 BC 16 vanA -* +
UW 3695 BC 17 -+ +
UW 3544 BC 17 vanA +-
#
UW 5352 BC 17 vanB -+
UW 6990 BC 18 -+ +
UW 1952 BC 18 vanA ++
UW 2900 BC 18 vanB +-
#
UW 1218 BC 19 vanA +-
#
UW 3056 BC 65 -+ +
UW 6880 BC 78 -+ +
UW 4671 BC 78 vanA +-
UW 2457 BC 80 vanA +-
UW 6985 BC 81 -- +
UW 2771 BC 81 vanA +-
UW 6882 BC 117 -+ -
UW 1983 BC 117 vanA +-
UW 6805 BC 125 vanA ++
UW 2824 BC 132 vanA +-
#
UW 1716 BC 192 -+ -
#
UW 5852 BC 192 vanA ++
UW 5267 BC 192 vanB +-
#
If available, different representatives of identical MLST types were considered
(see for instance ST17 vanA/B/-negative isolates).
PFGE, pulsed-field gel electrophoresis; MLST, Multi-locus sequence typing; BC,
blood culture; HC, human commensal; *, Hybridization signal with PFGE slot;
#,
negative results in repeated experiments.
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lowed by a replicase and relaxase genes indicated a sup-
posed plasmid origin of this contig (not shown in
details). Available sequence data allow extracting the
MLST type related allele information out of the
sequenced genomes and a corresponding analysis was
done on the seven (collection I) and eleven (collection
II) accessible genomes. Of the 11 isolates positive for
IS16 eight strains possessed hospital-associated MLST
types (ST16, ST17, ST18, ST78, ST203, ST-NEW) and
three did not belong to clonal complexes of hospital-
associated types (ST25, ST104, ST114). Intriguingly, of
the latter three, one was a clinical isolate also positive
for esp, a marker commonly associated only with hospi-
tal-associated strains.
Epidemiological analysis of clinical strains
We introduced PCR-based screening for IS16 for all
E. faecium isolates sent to our Focal Laboratory for
Enterocooci in Germany in late 2007. In 2008 we
received 314 E. faecium isolates (from >57 hospitals
l o c a t e di n1 3o ft h e1 6G e r m a nfederal states; all VRE)
and in 2009 334 E. faecium isolates (from >49 hospitals
located in 11 German federal states, 90% VRE) from
clinical sources for further analyses. Altogether 99.4%
(n = 312/314) in 2008 and 97.3% (n = 325/334) in 2009
were IS16-positive demonstrating wide prevalence of
multi-resistant (VRE), hospital-associated strain types in
hospitals in Germany.
Discussion
Early recognition of epidemic E. faecium strains is critical
for a timely introduction of strategies to prevent and con-
trol their further spread. Hospital-associated clonal types
of E. faecium often disseminate unrecognized among the
nosocomial setting before and until first VRE cases sud-
denly appear [5,6]. But standardised methods for rapid
diagnostics of these hospital-associated E. faecium strains
are missing and modern, DNA sequence-based typing
techniques are laborious, time-consuming and compar-
ably expensive. Acquired ampicillin resistance [5,6,34]
and high-level ciprofloxacin resistance [35,36] appear as
phenotypic traits of hospital-associated strains. However,
ampicillin resistance in animal or commensal enterococci
is also prevalent to a certain extent [37], at least in many
North American and Asian countries [38] and the predic-
tive value of acquired ciprofloxacin resistance is limited
since it accumulates over time and differently in various
clonal types of hospital strains [36]. Several genetic mar-
kers, such as esp, hylEfm or the purK1 allele (used as part
of the MLST scheme) are not ubiquitous traits of all hos-
pital-associated E. faecium strains and failure to detect
them does not reliably indicate a strain with a limited
spreading or pathogenic potential [27,34,36,39-41]. It was
also shown recently that hylEfm is plasmid-located
[11,42], transferable in vitro into several non-hospital E.
faecium strains and thus cannot be suggested to serve as
a specific marker to predict a clonal background of a
g i v e ns t r a i n[ 4 3 ] .Ar e l i a b l e and rapid molecular test to
differentiate commensal from hospital-acquired strains is
desirable; results from comparative genomic hybridiza-
tions and genome sequencing projects show promising
candidate markers including the described insertion ele-
ment IS16 [3].
According to our data, IS16 is highly specific for predict-
ing hospital-associated strain types (Table 1; Additional
files 1, 2, 3). Altogether 155 of the 160 blood culture iso-
lates from 1995 to 2007 from >50 contributing labora-
tories or hospitals and representing 28 MLST types were
all IS16 positive. The comparably high number of (a) parti-
cipating hospitals/laboratories contributing strains, (b)
blood culture strains representing many different MLST
types and different van genotypes, and (c) isolated from
over 13 years compensates for a geographical limitation of
a strain collection that only included isolates from Ger-
many. The presence of IS16 was independent of resistance
gene clusters known to possess this element; only 19 iso-
lates were vanB-positive (12%) and the remaining isolates
were vancomycin susceptible (n = 67; 42%) or of the
vanA-type (n = 74; 46%). Since it is known from previous
plasmid analysis that IS16 could be associated with specific
plasmid types (e.g., pRUM), we identified the location of
IS16 in a representative set of E. faecium isolates (vanA/
B/-negative; 29 MLST types; Table 2). Southern hybridiza-
tions revealed chromosomal, plasmid and both localiza-
tions for IS16 suggesting a somehow restricted mobile
gene pool within hospital-associated clonal types. All but
three investigated human commensal and all animal
strains possessed MLST types different from hospital-asso-
ciated strains; all but the three aforementioned strains
were IS16 negative. The three human commensal isolates
possessing IS16 revealed MLST types ST18 and ST413,
allocating them to hospital-associated strains and again
emphasising the excellent predictive value of this element
for identifiying hospital-associated strain types. PCRs for
esp and hylEfm were negative for these three strains and
one was ampicillin-resistant. Absence of IS16 among non-
clinical E. faecium strains also suggests a very limited host
range of IS16-bearing plasmids (e.g., pRUM-like) only
among hospital-associated strains. Prevalence of hospital-
associated E. faecium isolates among the general human
population is low and more detailed information was only
available in one of the three cases. This outpatient from a
community surveillance study received beta-lactam treat-
ment during the time of sampling which could be the rea-
son for identifying an ampicillin- and multiresistant,
epidemic strain here (association with a hospital stay was
not documented).
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isolates sent to our Focal Laboratory for Enterococci in
2008/2009 from German hospital patients revealed that
98% (n = 637) were IS16-positive, demonstrating country-
wide prevalence of hospital-associated strain types among
German hospitals in recent years. This finding was sup-
ported by wide prevalence of acquired high-level ciproflox-
acin resistance among the same strain collection serving as
an additional marker for hospital-associated strains [36].
Admittedly, most of the strains from 2008/2009 were van-
comycin-resistant showing in retrospect that hospital-
associated strains of E. faecium and not commensal strain
types accumulated in the nosocomial setting and acquired
vanA-o rvanB-type resistance determinants.
The observation that an IS element, IS16,i sa m o n g
the most specific markers to define hospital-associated
strains [3] appears curious regarding the promiscuous
nature of these elements to transpose between several
genomic backgrounds within a cell and the possible hor-
izontal mobilization in cis or trans by activation via con-
jugative elements and subsequent transfer into new
hosts. It has been argued that acquisition of specific ele-
ments, especially IS16, has contributed to the ecological
success of hospital-associated E. faecium strains allowing
higher levels of genetic variability including easier acqui-
sition of mobile genetic elements that may support life-
style in new or changing environments or ecological
niches like the hospital environment [3,44].
Conclusions
Our data show that an IS16-based screening assay
appears as the best molecular screening tool to differ-
entiate colonizing E. faecium isolates from hospital-asso-
ciated E. faecium strains that show an enhanced
spreading potential in the nosocomial setting. The pre-
dictive value of an IS16 result is superior to the predic-
tive strengths of established tests targeting molecular
markers like esp or hylEfm or phenotypic traits like
acquired ampicillin or high-level ciprofloxacin resis-
tance. Progress in comparative genome-based analysis
will most probably reveal additional markers to identify
hospital associated E. faecium isolates with an enhanced
spreading potential in the nosocomial setting [15,33].
Additional material
Additional file 1: Detailed information on the 160 clinical E. faecium
isolates. The blood culture strains were part of this study and of Werner
et al., [36]. “0” indicates absence, “1” indicates presence of the
corresponding marker (esp, hylEfm,I S 16, vanA/B/0). Legend: AmpR,
resistance to ampicillin; year, year of isolation.
Additional file 2: Detailed information on the 68 human commensal
E. faecium isolates. The human commensal strains were part of several
community prevalence studies performed in different parts of Germany
and at different time periods (see text for details). “0” indicates absence,
“1” indicates presence of the corresponding marker (esp, hylEfm,I S 16,
vanA/B/0). Legend: AmpR, resistance to ampicillin; year, year of isolation.
Additional file 3: Detailed information on the 32 animal E. faecium
isolates. The animal strains were part of several prevalence studies
performed in different parts of Germany and at different time periods
(see text for details). “0” indicates absence, “1” indicates presence of the
corresponding marker (esp, hylEfm,I S 16, vanA/B/0). Legend: AmpR,
resistance to ampicillin; year, year of isolation.
Additional file 4: goeBURST analysis of all MLST types of the E.
faecium database (n = 524 STs; 21.4.2010; http://efaecium.mlst.net/).
Only the major, superior complex without singletons and smaller
complexes is shown. A number of singletons from Figure 1 belong to
clonal complexes such as ST19 which is part of the large cluster and
related to CC17. Other complexes separated in Figure 1 (CC32, CC29) are
linked here to form a main, superior cluster. ST65 remains a singleton
and is the only IS16-positive ST not phylogenetically linked to the clonal
complex of hospital-associated strains (CC17).
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